Arsine Poisoning Clinical Presentation
- Author: Kermit D Huebner, MD, FACEP; Chief Editor: Robert G Darling, MD, FACEP more...
History
Most patients report little or no discomfort at the time of exposure. According to the Centers for Disease Control and Prevention (CDC), signs and symptoms generally occur 2-24 hours after exposure and are a result of massive hemolysis. Signs and symptoms include generalized weakness, dark urine, jaundice, and dyspnea. Oliguria and renal failure often occur 1-3 days after exposure.
A case series documenting comprehensive descriptions of the symptoms and clinical course of arsine toxicity was published in 1975.[6] Eight sailors were exposed to arsine gas that had escaped from a cylinder in the cargo hold of the Asiafreighter. Four sailors were exposed from 1 hour 5 minutes to 3 hours 45 minutes (cases 1-4). Four other sailors were exposed for approximately 15 minutes or less (cases 5-8).
All 8 sailors developed fever, headache, myalgia, epigastric pain, nausea, and vomiting between 1 and 12 hours of exposure. Cases 1-4 each developed intravascular hemolysis, renal failure, and marrow suppression with poor reticulocyte response and thrombocytopenia. Case 1 was exposed for the longest amount of time and suffered from anoxia and encephalopathy and was anuric for 5 weeks. Long-term complications for cases 1-4 included peripheral neuropathies, and case 1 was still severely disabled 6 months after the incident. Cases 5-8 developed much milder symptoms. All 8 sailors survived.
The CDC case definition of arsine poisoning includes the following:[7]
- Suspected: A case in which a potentially exposed person is being evaluated by health care worker or public health officials for poisoning by a particular chemical agent, but no specific credible threat exists.
- Probable: A clinically compatible case in which a high index of suspicion (credible threat or patient history regarding location and time) exists for arsine exposure, or an epidemiologic link exists between this case and a laboratory-confirmed case.
- Confirmed: A clinically compatible case in which laboratory tests have confirmed exposure.
The classic triad of symptoms in sublethal arsine exposures includes abdominal pain, hematuria, and jaundice. Symptoms by organ system are as follows:
- General - Fever, chills, shivering, thirst, malaise
- Cardiovascular - Long QT syndrome, hypovolemic shock, tachycardia, dysrhythmias
- Neurologic - Headache; dizziness; sensorimotor peripheral neuropathy (usually 1-3 wk after exposure); neuropsychological symptoms (several days after exposure) including memory loss, restlessness, and confusion
- Pulmonary - Dyspnea
- Gastrointestinal - Nausea, vomiting, abdominal pain, anorexia, jaundice
- Genitourinary - Red or dark-colored urine, flank pain, decreased urine output
- Muscle - Weakness, cramping
Physical
Physical signs and their severity depend on the concentration of arsine gas and the duration of the patient's exposure.
- Vital signs - Hyperthermia, tachypnea, tachycardia, hypotension
- Head, ears, eyes, nose, and throat (HEENT) - Discoloration of conjunctivae (red, orange, brown, or brassy; reportedly distinct from hyperbilirubinemia), scleral icterus, garlic odor to breath (possible)
- Pulmonary - Rales from acute respiratory distress syndrome (ARDS) in severe exposure
- Gastrointestinal - Abdominal tenderness, hepatomegaly
- Genitourinary - Costovertebral angle tenderness, colored urine (red, brown, or green from hemoglobinuria and/or methemoglobinuria)
- Extremities - Possible paresthesias and Mees lines with chronic arsenic toxicity from arsine exposure
Causes
- Arsine gas is used in the semiconductor industry when depositing arsenic on microchips. Exposure also may occur from producing, cleaning, or reclaiming gallium arsenide wafers.
- Arsine is released during the (usually accidental) production of hydrogen in an acid medium in contact with arsenic-contaminated metals.
- Arsine may potentially be used as a chemical warfare agent.
- Suspect arsine exposure if multiple victims present in a delayed fashion with hematuria, abdominal or flank pain, and jaundice.
- Severe acute arsine exposure may result in sudden death.
Blair PC, Thompson MB, Bechtold M, Wilson RE, Moorman MP, Fowler BA. Evidence for oxidative damage to red blood cells in mice induced by arsine gas. Toxicology. Jul 1990;63(1):25-34. [Medline].
Rael LT, Ayala-Fierro F, Carter DE. The effects of sulfur, thiol, and thiol inhibitor compounds on arsine-induced toxicity in the human erythrocyte membrane. Toxicol Sci. Jun 2000;55(2):468-77. [Medline].
Chowdhury R, Chowdhury S, Roychoudhury P, Mandal C, Chaudhuri K. Arsenic induced apoptosis in malignant melanoma cells is enhanced by menadione through ROS generation, p38 signaling and p53 activation. Apoptosis. Jan 2009;14(1):108-23. [Medline].
Dai CW, Zhang GS, Shen JK, Zheng WL, Pei MF, Xu YX, et al. Use of all-trans retinoic acid in combination with arsenic trioxide for remission induction in patients with newly diagnosed acute promyelocytic leukemia and for consolidation/maintenance in CR patients. Acta Haematol. 2009;121(1):1-8. [Medline].
Pullen-James S, Woods SE. Occupational arsine gas exposure. J Natl Med Assoc. Dec 2006;98(12):1998-2001. [Medline].
Wilkinson SP, McHugh P, Horsley S, Tubbs H, Lewis M, Thould A, et al. Arsine toxicity aboard the Asiafreighter. Br Med J. Sep 6 1975;3(5983):559-63. [Medline].
Centers for Disease Control and Prevention. Case Definition: Arsine or Stibine Poisoning. Emergency Preparedness and Response. Last updated March 4, 2005. Available at http://emergency.cdc.gov/agent/arsine/casedef.asp.
Centers for Disease Control and Prevention. Agency for Toxic Substances and Disease Registry. Medical Management Guidelines for Arsine. Last updated 9/24/07. Available at http://www.atsdr.cdc.gov/MHMI/mmg169.html. Accessed October 5, 2007.
Hesdorffer CS, Milne FJ, Terblanche J, Meyers AM. Arsine gas poisoning: the importance of exchange transfusions in severe cases. Br J Ind Med. May 1986;43(5):353-5. [Medline].
Teitelbaum DT, Kier LC. Arsine poisoning. Report of five cases in the petroleum industry and a discussion of the indications for exchange transfusion and hemodialysis. Arch Environ Health. Jul 1969;19(1):133-43. [Medline].
Pullen-James S, Woods SE. Occupational arsine gas exposure. J Natl Med Assoc. Dec 2006;98(12):1998-2001. [Medline].
Danielson C, Houseworth J, Skipworth E, Smith D, McCarthy L, Nanagas K. Arsine toxicity treated with red blood cell and plasma exchanges. Transfusion. Sep 2006;46(9):1576-9. [Medline].
Song Y, Wang D, Li H, Hao F, Ma J, Xia Y. Severe acute arsine poisoning treated by plasma exchange. Clin Toxicol (Phila). Sep 2007;45(6):721-7. [Medline].
Anthonisen P, Nielsen B, Pedersen K, Raaschou F. 3. Clinical picture and treatment in arsine poisoning. Acta Med Scand Suppl. 1968;496:14-22. [Medline].
Caravati, Martin E. Arsenic and arsine gas. In: Dart RC. Medical Toxicology. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004:1393-1401/chap 213.
Fowler BA, Weissberg JB. Arsine poisoning. N Engl J Med. Nov 28 1974;291(22):1171-4. [Medline].
Huq MA, Parveen F, Choudhury SR. A cheap and convenient modification of arsine generator used for arsenic estimation. Mymensingh Med J. Jan 2003;12(1):30-2. [Medline].
Klimecki WT, Carter DE. Arsine toxicity: chemical and mechanistic implications. J Toxicol Environ Health. Dec 1995;46(4):399-409. [Medline].
Levinsky WJ, Smalley RV, Hillyer PN, Shindler RL. Arsine hemolysis. Arch Environ Health. Mar 1970;20(3):436-40. [Medline].

